Rhumbline Advisers Has $268,000 Stock Holdings in Allogene Therapeutics, Inc. (NASDAQ:ALLO)
Rhumbline Advisers trimmed its holdings in shares of Allogene Therapeutics, Inc. (NASDAQ:ALLO – Free Report) by 4.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 183,708 shares of the company’s stock after selling 8,006 shares during the quarter. Rhumbline Advisers’ holdings in Allogene […]
Rhumbline Advisers trimmed its holdings in shares of Allogene Therapeutics, Inc. (NASDAQ:ALLO – Free Report) by 4.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 183,708 shares of the company’s stock after selling 8,006 shares during the quarter. Rhumbline Advisers’ holdings in Allogene […]
